{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Description in input context": "A53T"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease",
        "MONDO": "MONDO:0005148"
    },
    "Experiment Method": [
        {
            "Assay Method": "Enzyme activity assay",
            "Material used": {
                "Material Source": "Cell line/Recombinant proteins",
                "Material Name": "Sf9 cells, recombinant hPLD2, wild - type and mutant synuclein proteins",
                "Description": "hPLD2 was expressed in Sf9 cells and purified. Wild - type and mutant synuclein proteins were also purified. The experiment used these proteins and lipid vesicles for the assay."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "A30P inhibition was not different from wild - type, A53T mutant had a greater inhibitory effect",
                    "Molecular Effect": "A53T may have a gain - of - function",
                    "Result Description": "Increasing concentrations of wild - type hAS induced a sigmoidal decrease in hPLD2 activity. A30P inhibition was similar to wild - type, while A53T mutant had enhanced inhibition of PLD2 compared to wild - type hAS"
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Means Â± SD for three or four separate experiments are shown for the hPLD2 inhibition assays"
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "The General Linear Model was used to perform analysis of covariates (ANCOVA) to compare slopes between proteins"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Circular dichroism spectroscopy",
            "Material used": {
                "Material Source": "Recombinant proteins",
                "Material Name": "hAS and the mutants DYD and S129E",
                "Description": "CD spectra were collected for hAS and the mutants DYD and S129E using a JASCO J - 720 spectropolarimeter in the presence of lipid vesicles"
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "Both mutants were unstructured in the absence of lipid, but assumed an a - helical conformation in the presence of vesicles",
                    "Molecular Effect": "N.D.",
                    "Result Description": "Both mutants DYD and S129E were unstructured in the absence of lipid, but assumed an a - helical conformation in the presence of vesicles, with a slight decrement in a - helix content as estimated from the circular dichroism spectra"
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "Custom"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "Custom"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}